{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T04:17:43Z","timestamp":1792124263691,"version":"4.4.0"},"reference-count":287,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2018,9,9]],"date-time":"2018-09-09T00:00:00Z","timestamp":1536451200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2018,9,9]],"date-time":"2018-09-09T00:00:00Z","timestamp":1536451200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1111\/bjd.16808","type":"journal-article","created":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T17:59:21Z","timestamp":1527098361000},"page":"1033-1048","source":"Crossref","is-referenced-by-count":282,"title":["Alopecia areata: a review of disease pathogenesis"],"prefix":"10.1093","volume":"179","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5994-1997","authenticated-orcid":false,"given":"F.","family":"Rajabi","sequence":"first","affiliation":[{"name":"Department of Dermatology; School of Medicine; Shahid Beheshti University of Medical Sciences; Tehran Iran"},{"name":"Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA); Universal Scientific Education and Research Network (USERN); Tehran Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.A.","family":"Drake","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital; Harvard Medical School; MA U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.M.","family":"Senna","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital; Harvard Medical School; MA U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Rezaei","sequence":"additional","affiliation":[{"name":"Research Center for Immunodeficiencies; Children's Medical Center; Tehran University of Medical Sciences; Tehran Iran"},{"name":"Department of Immunology; School of Medicine; Tehran University of Medical Sciences; Tehran Iran"},{"name":"Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA); Universal Scientific Education and Research Network (USERN); Sheffield U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,9,9]]},"reference":[{"key":"10.1111\/bjd.16808-BIB0001|bjd16808-cit-0001","doi-asserted-by":"crossref","first-page":"628","DOI":"10.4065\/70.7.628","article-title":"Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989","volume":"70","author":"Safavi","year":"1995","journal-title":"Mayo Clin Proc"},{"key":"10.1111\/bjd.16808-BIB0002|bjd16808-cit-0002","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/jid.2013.464","article-title":"Lifetime incidence risk of alopecia areata estimated at 2.1 percent by Rochester Epidemiology Project, 1990-2009","volume":"134","author":"Mirzoyev","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16808-BIB0003|bjd16808-cit-0003","first-page":"397","article-title":"Epidemiology and burden of alopecia areata: a systematic review","volume":"8","author":"Fricke","year":"2015","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"10.1111\/bjd.16808-BIB0004|bjd16808-cit-0004","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1038\/jidsymp.2013.18","article-title":"Health-related quality of life (HRQoL) in alopecia areata patients - a secondary analysis of the National Alopecia Areata Registry Data","volume":"16","author":"Shi","year":"2013","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1111\/bjd.16808-BIB0005|bjd16808-cit-0005","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/bjd.14497","article-title":"Alopecia areata and health-related quality of life: a systematic review and meta-analysis","volume":"175","author":"Rencz","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.16808-BIB0006|bjd16808-cit-0006","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.jaad.2016.04.035","article-title":"Health-related quality of life (HRQoL) among patients with alopecia areata (AA): a systematic review","volume":"75","author":"Liu","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.16808-BIB0007|bjd16808-cit-0007","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jaad.2008.03.031","article-title":"The role of scalp dermoscopy in the diagnosis of alopecia areata incognita","volume":"59","author":"Tosti","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.16808-BIB0008|bjd16808-cit-0008","first-page":"356","article-title":"Diagnosing and treating hair loss","volume":"80","author":"Mounsey","year":"2009","journal-title":"Am Fam Physician"},{"key":"10.1111\/bjd.16808-BIB0009|bjd16808-cit-0009","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.autrev.2014.10.014","article-title":"The autoimmune basis of alopecia areata: a comprehensive review","volume":"14","author":"Islam","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1111\/bjd.16808-BIB0010|bjd16808-cit-0010","first-page":"CD004413","article-title":"Interventions for alopecia areata","volume":"16","author":"Delamere","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/bjd.16808-BIB0011|bjd16808-cit-0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000254233","article-title":"Produced alopecia areata based on the focal infection theory and mental motive theory","volume":"134","author":"Ikeda","year":"1967","journal-title":"Dermatology"},{"key":"10.1111\/bjd.16808-BIB0012|bjd16808-cit-0012","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/jid.1958.73","article-title":"Morphologic changes in pilosebaceous units and anagen hairs in alopecia areata","volume":"31","author":"Van Scott","year":"1958","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16808-BIB0013|bjd16808-cit-0013","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1600-0625.1999.tb00385.x","article-title":"Alopecia areata: an autoimmune disease?","volume":"8","author":"McElwee","year":"1999","journal-title":"Exp Dermatol"},{"key":"10.1111\/bjd.16808-BIB0014|bjd16808-cit-0014","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/j.1468-3083.2006.01676.x","article-title":"Profile of 513 patients with alopecia areata: associations of disease subtypes with atopy, autoimmune disease and positive family history","volume":"20","author":"Goh","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.16808-BIB0015|bjd16808-cit-0015","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2147\/CCID.S10182","article-title":"Alopecia: evaluation and treatment","volume":"4","author":"Gordon","year":"2011","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"10.1111\/bjd.16808-BIB0016|bjd16808-cit-0016","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jaad.2009.10.031","article-title":"Alopecia areata update: part II. Treatment","volume":"62","author":"Alkhalifah","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.16808-BIB0017|bjd16808-cit-0017","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/exd.12209","article-title":"What causes alopecia areata?","volume":"22","author":"McElwee","year":"2013","journal-title":"Exp Dermatol"},{"key":"10.1111\/bjd.16808-BIB0018|bjd16808-cit-0018","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2340\/0001555572373375","article-title":"The genetic risk for alopecia areata in first degree relatives of severely affected patients. An estimate","volume":"72","author":"Van der Steen","year":"1992","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/bjd.16808-BIB0019|bjd16808-cit-0019","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1046\/j.1365-2230.2002.01077.x","article-title":"Epidemiology and genetics of alopecia areata","volume":"27","author":"McDonagh","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/bjd.16808-BIB0020|bjd16808-cit-0020","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0190-9622(98)70499-2","article-title":"Alopecia areata and cytomegalovirus infection in twins: genes versus environment?","volume":"38","author":"Jackow","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.16808-BIB0021|bjd16808-cit-0021","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/00000658-197211000-00004","article-title":"Analysis of local anatomic factors that influence the survival times of pure epidermal and full-thickness skin homografts in guinea pigs","volume":"176","author":"Barker","year":"1972","journal-title":"Ann Surg"},{"key":"10.1111\/bjd.16808-BIB0022|bjd16808-cit-0022","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/46938","article-title":"Trans-gender induction of hair follicles","volume":"402","author":"Reynolds","year":"1999","journal-title":"Nature"},{"key":"10.1111\/bjd.16808-BIB0023|bjd16808-cit-0023","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/1523-1747.ep12261543","article-title":"A biologist's reflections on dermatology","volume":"57","author":"Billingham","year":"1971","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16808-BIB0024|bjd16808-cit-0024","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0002-9440(10)63151-3","article-title":"Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model","volume":"164","author":"Ito","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1111\/bjd.16808-BIB0025|bjd16808-cit-0025","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1038\/jid.2010.260","article-title":"Collapse of immune privilege in alopecia areata: coincidental or substantial?","volume":"130","author":"Gilhar","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16808-BIB0026|bjd16808-cit-0026","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1046\/j.1087-0024.2003.00807.x","article-title":"The hair follicle and immune privilege","volume":"8","author":"Paus","year":"2003","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1111\/bjd.16808-BIB0027|bjd16808-cit-0027","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/jid.2013.368","article-title":"Hair follicle mesenchyme-associated PD-L1 regulates T-cell activation induced apoptosis: a potential mechanism of immune privilege","volume":"134","author":"Wang","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16808-BIB0028|bjd16808-cit-0028","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1046\/j.1365-2133.2000.03464.x","article-title":"The human hair follicle immune system: cellular composition and immune privilege","volume":"142","author":"Christoph","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.16808-BIB0029|bjd16808-cit-0029","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1038\/jid.2010.180","article-title":"Hair follicles from alopecia areata patients exhibit alterations in immune privilege-associated gene expression in advance of hair loss","volume":"130","author":"Kang","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16808-BIB0030|bjd16808-cit-0030","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1600-065X.2006.00430.x","article-title":"A vision of cell death: Fas ligand and immune privilege 10 years later","volume":"213","author":"Ferguson","year":"2006","journal-title":"Immunol Rev"},{"key":"10.1111\/bjd.16808-BIB0031|bjd16808-cit-0031","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1126\/science.270.5239.1189","article-title":"Fas ligand-induced apoptosis as a mechanism of immune privilege","volume":"270","author":"Griffith","year":"1995","journal-title":"Science"},{"key":"10.1111\/bjd.16808-BIB0032|bjd16808-cit-0032","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/jid.2013.53","article-title":"Somatostatin expression in human hair follicles and its potential role in immune privilege","volume":"133","author":"Breitkopf","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16808-BIB0033|bjd16808-cit-0033","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1600-0625.2011.01432.x","article-title":"Calcitonin gene-related peptide (CGRP) may award relative protection from interferon-\u03b3-induced collapse of human hair follicle immune privilege","volume":"21","author":"Kinori","year":"2012","journal-title":"Exp Dermatol"},{"key":"10.1111\/bjd.16808-BIB0034|bjd16808-cit-0034","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.1365-2133.1996.tb07940.x","article-title":"In situ analysis of transforming growth factors-\u03b2 (TGF-\u03b21, TGF-\u03b22, TGF-\u03b23) and TGF-\u03b2 type II receptor expression in basal cell carcinomas","volume":"134","author":"Schmid","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.16808-BIB0035|bjd16808-cit-0035","first-page":"658","article-title":"Detection of proopiomelanocortin-derived antigens in normal and pathological human skin","volume":"122","author":"Slominski","year":"1993","journal-title":"J Lab Clin Med"},{"key":"10.1111\/bjd.16808-BIB0036|bjd16808-cit-0036","first-page":"1077","article-title":"Evidence that the bulge region is a site of relative immune privilege in human hair follicles","volume":"159","author":"Meyer","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.16808-BIB0037|bjd16808-cit-0037","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/08830180801911743","article-title":"Potential role of NK cells in the induction of immune responses: implications for NK cell-based immunotherapy for cancers and viral infections","volume":"27","author":"Terunuma","year":"2008","journal-title":"Int Rev Immunol"},{"key":"10.1111\/bjd.16808-BIB0038|bjd16808-cit-0038","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1034\/j.1600-065X.2001.1810117.x","article-title":"Human natural killer cell receptors and co-receptors","volume":"181","author":"Biassoni","year":"2001","journal-title":"Immunol Rev"},{"key":"10.1111\/bjd.16808-BIB0039|bjd16808-cit-0039","volume-title":"Immunobiology","author":"Janeway","year":"2005"},{"key":"10.1111\/bjd.16808-BIB0040|bjd16808-cit-0040","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/eji.1830270230","article-title":"The CD94 and NKG2-AC-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules","volume":"27","author":"Carretero","year":"1997","journal-title":"Eur J Immunol"},{"key":"10.1111\/bjd.16808-BIB0041|bjd16808-cit-0041","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1034\/j.1600-065X.2001.1810119.x","article-title":"Inhibition of natural killer cell activation signals by killer cell immunoglobulin-like receptors (CD158)","volume":"181","author":"Long","year":"2001","journal-title":"Immunol Rev"},{"key":"10.1111\/bjd.16808-BIB0042|bjd16808-cit-0042","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3389\/fimmu.2015.00193","article-title":"The impact of glycosyl-phosphatidyl-inositol anchored MICA alleles on novel NKG2D-based therapies","volume":"6","author":"Val\u00e9s-G\u00f3mez","year":"2015","journal-title":"Front Immunol"},{"key":"10.1111\/bjd.16808-BIB0043|bjd16808-cit-0043","doi-asserted-by":"crossref","first-page":"12445","DOI":"10.1073\/pnas.93.22.12445","article-title":"Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium","volume":"93","author":"Groh","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/bjd.16808-BIB0044|bjd16808-cit-0044","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0304-4165(01)00099-X","article-title":"Oxidative stress increases MICA and MICB gene expression in the human colon carcinoma cell line (CaCo-2)","volume":"1526","author":"Yamamoto","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"10.1111\/bjd.16808-BIB0045|bjd16808-cit-0045","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0167-5699(90)90097-S","article-title":"In search of the \u2018missing self\u2019: MHC molecules and NK cell recognition","volume":"11","author":"Ljunggren","year":"1990","journal-title":"Immunol Today"},{"key":"10.1111\/bjd.16808-BIB0046|bjd16808-cit-0046","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1600-065X.2006.00458.x","article-title":"Licensing of natural killer cells by self-major histocompatibility complex class I","volume":"214","author":"Yokoyama","year":"2006","journal-title":"Immunol Rev"},{"key":"10.1111\/bjd.16808-BIB0047|bjd16808-cit-0047","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1600-065X.2006.00460.x","article-title":"Activation and self-tolerance of natural killer cells","volume":"214","author":"Gasser","year":"2006","journal-title":"Immunol Rev"},{"key":"10.1111\/bjd.16808-BIB0048|bjd16808-cit-0048","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev.immunol.23.021704.115526","article-title":"NK cell recognition","volume":"23","author":"Lanier","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"10.1111\/bjd.16808-BIB0049|bjd16808-cit-0049","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/sj.jid.5701183","article-title":"Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack","volume":"128","author":"Ito","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16808-BIB0050|bjd16808-cit-0050","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.4049\/jimmunol.160.12.5693","article-title":"Cutting edge: role of macrophage migration inhibitory factor in inhibiting NK cell activity and preserving immune privilege","volume":"160","author":"Apte","year":"1998","journal-title":"J Immunol"},{"key":"10.1111\/bjd.16808-BIB0051|bjd16808-cit-0051","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00281-007-0074-3","article-title":"The role of macrophage migration inhibitory factor in maintaining the immune privilege at the fetal-maternal interface","volume":"29","author":"Vigan\u00f2","year":"2007","journal-title":"Semin Immunopathol"},{"key":"10.1111\/bjd.16808-BIB0052|bjd16808-cit-0052","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/j.0022-202X.2005.23927.x","article-title":"Immunology of the human nail apparatus: the nail matrix is a site of relative immune privilege","volume":"125","author":"Ito","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16808-BIB0053|bjd16808-cit-0053","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1530\/rep.1.00857","article-title":"Human decidual natural killer cells as a source and target of macrophage migration inhibitory factor","volume":"131","author":"Arcuri","year":"2006","journal-title":"Reproduction"},{"key":"10.1111\/bjd.16808-BIB0054|bjd16808-cit-0054","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1046\/j.0022-202x.2001.01669.x","article-title":"Increased macrophage migration inhibitory factor (MIF) in the sera of patients with extensive alopecia areata","volume":"118","author":"Shimizu","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16808-BIB0055|bjd16808-cit-0055","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/sj.gene.6364191","article-title":"Promoter region polymorphism of macrophage migration inhibitory factor is strong risk factor for young onset of extensive alopecia areata","volume":"6","author":"Shimizu","year":"2005","journal-title":"Genes Immun"},{"key":"10.1111\/bjd.16808-BIB0056|bjd16808-cit-0056","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/jcla.21731","article-title":"Serum level of macrophage migration inhibitory factor (MIF) in Egyptians with alopecia areata and its relation to the clinical severity of the disease","volume":"29","author":"Younan","year":"2015","journal-title":"J Clin Lab Anal"},{"key":"10.1111\/bjd.16808-BIB0057|bjd16808-cit-0057","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/ijd.13344","article-title":"Evaluation of macrophage migration inhibitory factor (MIF) levels in serum and lesional skin of patients with alopecia areata","volume":"55","author":"Salem","year":"2016","journal-title":"Int J Dermatol"},{"key":"10.1111\/bjd.16808-BIB0058|bjd16808-cit-0058","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.autrev.2008.07.037","article-title":"MIF in autoimmunity and novel therapeutic approaches","volume":"8","author":"Stosic-Grujicic","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1111\/bjd.16808-BIB0059|bjd16808-cit-0059","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1046\/j.0022-202x.2001.01366.x","article-title":"High macrophage migration inhibitory factor (MIF) serum levels associated with extended psoriasis","volume":"116","author":"Shimizu","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16808-BIB0060|bjd16808-cit-0060","first-page":"268","article-title":"Macrophage migration inhibitory factor in systemic lupus erythematosus","volume":"31","author":"Foote","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1111\/bjd.16808-BIB0061|bjd16808-cit-0061","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0022-510X(00)00397-X","article-title":"Macrophage migration inhibitory factor in the cerebrospinal fluid of patients with conventional and optic-spinal forms of multiple sclerosis and neuro-Beh\u00e7et's disease","volume":"179","author":"Niino","year":"2000","journal-title":"J Neurol Sci"},{"key":"10.1111\/bjd.16808-BIB0062|bjd16808-cit-0062","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1210\/en.2004-1393","article-title":"Critical role of macrophage migration inhibitory factor activity in experimental autoimmune diabetes","volume":"146","author":"Cvetkovic","year":"2005","journal-title":"Endocrinology"},{"key":"10.1111\/bjd.16808-BIB0063|bjd16808-cit-0063","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1358\/dnp.2010.23.4.1453629","article-title":"Macrophage migration inhibitory factor (MIF): a promising biomarker","volume":"23","author":"Grieb","year":"2010","journal-title":"Drug News Perspect"},{"key":"10.1111\/bjd.16808-BIB0064|bjd16808-cit-0064","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.humimm.2012.05.009","article-title":"HLA-G polymorphisms and soluble HLA-G protein levels in women with recurrent pregnancy loss from Basrah province in Iraq","volume":"73","author":"Jassem","year":"2012","journal-title":"Hum Immunol"},{"key":"10.1111\/bjd.16808-BIB0065|bjd16808-cit-0065","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/TP.0b013e31821414c9","article-title":"HLA-G level on monocytoid dendritic cells correlates with regulatory T cell Foxp3 expression in liver transplant tolerance","volume":"91","author":"Castellaneta","year":"2011","journal-title":"Transplantation"},{"key":"10.1111\/bjd.16808-BIB0066|bjd16808-cit-0066","first-page":"541","article-title":"Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb?","volume":"66","author":"Paus","year":"1993","journal-title":"Yale J Biol Med"},{"key":"10.1111\/bjd.16808-BIB0067|bjd16808-cit-0067","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0190-9622(84)70152-6","article-title":"T cell subpopulations in alopecia areata","volume":"11","author":"Todes-Taylor","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.16808-BIB0068|bjd16808-cit-0068","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/1523-1747.ep12470166","article-title":"Abnormal expression of class I and class II major histocompatibility antigens in alopecia areata: modulation by topical immunotherapy","volume":"88","author":"Br\u00f6cker","year":"1987","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16808-BIB0069|bjd16808-cit-0069","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/1523-1747.ep12277414","article-title":"Expression of HLA-DR by anagen hair follicles in alopecia areata","volume":"85","author":"Messenger","year":"1985","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16808-BIB0070|bjd16808-cit-0070","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/1523-1747.ep12462213","article-title":"HLA-DR expression by hair follicle keratinocytes in alopecia areata: evidence that it is secondary to the lymphoid infiltration","volume":"90","author":"Khoury","year":"1988","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16808-BIB0071|bjd16808-cit-0071","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ygeno.2010.05.002","article-title":"Transcriptional profiling in alopecia areata defines immune and cell cycle control related genes within disease-specific signatures","volume":"96","author":"Subramanya","year":"2010","journal-title":"Genomics"},{"key":"10.1111\/bjd.16808-BIB0072|bjd16808-cit-0072","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jdermsci.2012.12.003","article-title":"CXCL10 produced from hair follicles induces Th1 and Tc1 cell infiltration in the acute phase of alopecia areata followed by sustained Tc1 accumulation in the chronic phase","volume":"69","author":"Ito","year":"2013","journal-title":"J Dermatol Sci"},{"key":"10.1111\/bjd.16808-BIB0073|bjd16808-cit-0073","first-page":"33","article-title":"Interferon-\u03b3 in alopecia areata","volume":"14","author":"Ercan","year":"2004","journal-title":"Eur J Dermatol"},{"key":"10.1111\/bjd.16808-BIB0074|bjd16808-cit-0074","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1365-2133.1993.tb11842.x","article-title":"HLA and ICAM-1 expression in alopecia areata in vivo and in vitro: the role of cytokines","volume":"129","author":"McDonagh","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.16808-BIB0075|bjd16808-cit-0075","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1111\/1523-1747.ep12472216","article-title":"Aberrant intercellular adhesion molecule-1 (ICAM-1) expression by hair-follicle epithelial cells and endothelial leucocyte adhesion molecule-1 (ELAM-1) by vascular cells are important adhesion-molecule alterations in alopecia areata","volume":"96","author":"Nickoloff","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16808-BIB0076|bjd16808-cit-0076","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1365-2133.2006.07377.x","article-title":"Interferon-\u03b3-deficient mice are resistant to the development of alopecia areata","volume":"155","author":"Freyschmidt-Paul","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.16808-BIB0077|bjd16808-cit-0077","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nm.3645","article-title":"Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition","volume":"20","author":"Xing","year":"2014","journal-title":"Nat Med"},{"key":"10.1111\/bjd.16808-BIB0078|bjd16808-cit-0078","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.0022-202X.2004.23580.x","article-title":"Alopecia areata induced in C3H\/HeJ mice by interferon-\u03b3: evidence for loss of immune privilege","volume":"124","author":"Gilhar","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16808-BIB0079|bjd16808-cit-0079","first-page":"43","article-title":"Oxidative stress and alopecia areata","volume":"8","author":"Prie","year":"2015","journal-title":"J Med Life"},{"key":"10.1111\/bjd.16808-BIB0080|bjd16808-cit-0080","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s40257-013-0036-6","article-title":"Oxidative stress in alopecia areata: a case-control study","volume":"15","author":"Bakry","year":"2014","journal-title":"Am J Clin Dermatol"},{"key":"10.1111\/bjd.16808-BIB0081|bjd16808-cit-0081","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1126\/science.285.5428.727","article-title":"Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA","volume":"285","author":"Bauer","year":"1999","journal-title":"Science"},{"key":"10.1111\/bjd.16808-BIB0082|bjd16808-cit-0082","doi-asserted-by":"crossref","DOI":"10.1159\/000485080","article-title":"Immune privilege collapse and alopecia development: is stress a factor","author":"Azzawi","year":"2018","journal-title":"Skin Append Disord"},{"key":"10.1111\/bjd.16808-BIB0083|bjd16808-cit-0083","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/ced.12556","article-title":"Investigation of oxidative stress in patients with alopecia areata and its relationship with disease severity, duration, recurrence and pattern","volume":"40","author":"Yenin","year":"2015","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/bjd.16808-BIB0084|bjd16808-cit-0084","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1046\/j.0022-202x.2001.01583.x","article-title":"Melanocyte-associated T cell epitopes can function as autoantigens for transfer of alopecia areata to human scalp explants on Prkdc scid mice","volume":"117","author":"Gilhar","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16808-BIB0085|bjd16808-cit-0085","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1529-8019.2011.01416.x","article-title":"Etiopathogenesis of alopecia areata: why do our patients get it?","volume":"24","author":"Wang","year":"2011","journal-title":"Dermatol Ther"},{"key":"10.1111\/bjd.16808-BIB0086|bjd16808-cit-0086","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.1021\/pr100422u","article-title":"Trichohyalin is a potential major autoantigen in human alopecia areata","volume":"9","author":"Leung","year":"2010","journal-title":"J Proteome Res"},{"key":"10.1111\/bjd.16808-BIB0087|bjd16808-cit-0087","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0738-081X(00)00134-6","article-title":"Alopecia areata","volume":"19","author":"McDonagh","year":"2001","journal-title":"Clin Dermatol"},{"key":"10.1111\/bjd.16808-BIB0088|bjd16808-cit-0088","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/jid.1995.30","article-title":"Is the dermal papilla a primary target in alopecia areata?","volume":"104","author":"Randall","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16808-BIB0089|bjd16808-cit-0089","doi-asserted-by":"crossref","first-page":"9452","DOI":"10.1073\/pnas.1632807100","article-title":"Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis","volume":"100","author":"Groh","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/bjd.16808-BIB0090|bjd16808-cit-0090","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1074-7613(02)00505-8","article-title":"Impairment of NK cell function by NKG2D modulation in NOD mice","volume":"18","author":"Ogasawara","year":"2003","journal-title":"Immunity"},{"key":"10.1111\/bjd.16808-BIB0091|bjd16808-cit-0091","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.immuni.2004.05.008","article-title":"NKG2D blockade prevents autoimmune diabetes in NOD mice","volume":"20","author":"Ogasawara","year":"2004","journal-title":"Immunity"},{"key":"10.1111\/bjd.16808-BIB0092|bjd16808-cit-0092","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jdermsci.2015.01.004","article-title":"The genetics of alopecia areata: new approaches, new findings, new treatments","volume":"78","author":"Biran","year":"2015","journal-title":"J Dermatol Sci"},{"key":"10.1111\/bjd.16808-BIB0093|bjd16808-cit-0093","doi-asserted-by":"crossref","first-page":"5966","DOI":"10.1038\/ncomms6966","article-title":"Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci","volume":"6","author":"Betz","year":"2015","journal-title":"Nat Commun"},{"key":"10.1111\/bjd.16808-BIB0094|bjd16808-cit-0094","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.molimm.2009.02.023","article-title":"The role of the activating receptor NKG2D in autoimmunity","volume":"47","author":"Van Belle","year":"2009","journal-title":"Mol Immunol"},{"key":"10.1111\/bjd.16808-BIB0095|bjd16808-cit-0095","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/j.0022-202X.2005.23692.x","article-title":"Transfer of CD8+ cells induces localized hair loss whereas CD4+\/CD25\u2212 cells promote systemic alopecia areata and CD4+\/CD25+ cells blockade disease onset in the C3H\/HeJ mouse model","volume":"124","author":"McElwee","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16808-BIB0096|bjd16808-cit-0096","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000085580","article-title":"What can we learn from animal models of alopecia areata?","volume":"211","author":"McElwee","year":"2005","journal-title":"Dermatology"},{"key":"10.1111\/bjd.16808-BIB0097|bjd16808-cit-0097","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1046\/j.1523-1747.2002.01745.x","article-title":"Transient CD44 variant isoform expression and reduction in CD4+\/CD25+ regulatory T cells in C3H\/HeJ mice with alopecia areata","volume":"118","author":"Z\u00f6ller","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16808-BIB0098|bjd16808-cit-0098","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/1523-1747.ep12382416","article-title":"Alopecia areata in ageing C3H\/HeJ mice","volume":"102","author":"Sundberg","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16808-BIB0099|bjd16808-cit-0099","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1046\/j.1365-2230.2002.01075.x","article-title":"Alopecia areata \u2212 animal models","volume":"27","author":"McElwee","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/bjd.16808-BIB0100|bjd16808-cit-0100","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1046\/j.1523-1747.1998.00380.x","article-title":"Experimental induction of alopecia areata-like hair loss in C3H\/HeJ mice using full-thickness skin grafts","volume":"111","author":"McElwee","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16808-BIB0101|bjd16808-cit-0101","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/archderm.1987.01660250050016","article-title":"Hair growth in scalp grafts from patients with alopecia areata and alopecia universalis grafted onto nude mice","volume":"123","author":"Gilhar","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.16808-BIB0102|bjd16808-cit-0102","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1038\/jid.2015.176","article-title":"Transfer of alopecia areata to C3H\/HeJ mice using cultured lymph node-derived cells","volume":"135","author":"Wang","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16808-BIB0103|bjd16808-cit-0103","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.cyto.2008.01.003","article-title":"Interleukin-15 improves cytotoxicity of natural killer cells via up-regulating NKG2D and cytotoxic effector molecule expression as well as STAT1 and ERK1\/2 phosphorylation","volume":"42","author":"Zhang","year":"2008","journal-title":"Cytokine"},{"key":"10.1111\/bjd.16808-BIB0104|bjd16808-cit-0104","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1172\/JCI551","article-title":"Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice","volume":"101","author":"Gilhar","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1111\/bjd.16808-BIB0105|bjd16808-cit-0105","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/sj.jidsp.5640212","article-title":"Alopecia areata is a T-lymphocyte mediated autoimmune disease: lesional human T-lymphocytes transfer alopecia areata to human skin grafts on SCID mice","volume":"4","author":"Gilhar","year":"1999","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1111\/bjd.16808-BIB0106|bjd16808-cit-0106","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.exphem.2010.02.006","article-title":"Natural-killer cell amplification for adoptive leukemia relapse immunotherapy: comparison of three cytokines, IL-2, IL-15, or IL-7 and impact on NKG2D, KIR2DL1, and KIR2DL2 expression","volume":"38","author":"Decot","year":"2010","journal-title":"Exp Haematol"},{"key":"10.1111\/bjd.16808-BIB0107|bjd16808-cit-0107","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1056\/NEJMra1103442","article-title":"Alopecia areata","volume":"366","author":"Gilhar","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1111\/bjd.16808-BIB0108|bjd16808-cit-0108","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/jid.2012.365","article-title":"Autoimmune disease induction in a healthy human organ: a humanized mouse model of alopecia areata","volume":"133","author":"Gilhar","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16808-BIB0109|bjd16808-cit-0109","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/j.1365-2133.2006.07166.x","article-title":"Dermatological manifestations of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome","volume":"154","author":"Collins","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.16808-BIB0110|bjd16808-cit-0110","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1038\/nri2450","article-title":"Transcriptional regulation by AIRE: molecular mechanisms of central tolerance","volume":"8","author":"Peterson","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/bjd.16808-BIB0111|bjd16808-cit-0111","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1126\/science.1075958","article-title":"Projection of an immunological self shadow within the thymus by the aire protein","volume":"298","author":"Anderson","year":"2002","journal-title":"Science"},{"key":"10.1111\/bjd.16808-BIB0112|bjd16808-cit-0112","doi-asserted-by":"crossref","first-page":"7173","DOI":"10.4049\/jimmunol.178.11.7173","article-title":"The autoimmune regulator directly controls the expression of genes critical for thymic epithelial function","volume":"178","author":"Ruan","year":"2007","journal-title":"J Immunol"},{"key":"10.1111\/bjd.16808-BIB0113|bjd16808-cit-0113","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.autrev.2005.09.001","article-title":"Disruption of immunological tolerance: role of AIRE gene in autoimmunity","volume":"5","author":"Rizzi","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1111\/bjd.16808-BIB0114|bjd16808-cit-0114","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/ni906","article-title":"Aire regulates negative selection of organ-specific T cells","volume":"4","author":"Liston","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1111\/bjd.16808-BIB0115|bjd16808-cit-0115","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fimmu.2014.00051","article-title":"Lymphopenia-induced proliferation in aire-deficient mice helps to explain their autoimmunity and differences from human patients","volume":"5","author":"Kisand","year":"2014","journal-title":"Front Immunol"},{"key":"10.1111\/bjd.16808-BIB0116|bjd16808-cit-0116","first-page":"591","article-title":"The autoimmune regulator gene (AIRE) is strongly associated with vitiligo","volume":"159","author":"Tazi-Ahnini","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.16808-BIB0117|bjd16808-cit-0117","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1034\/j.1399-0039.2002.600604.x","article-title":"Role of the autoimmune regulator (AIRE) gene in alopecia areata: strong association of a potentially functional AIRE polymorphism with alopecia universalis","volume":"60","author":"Tazi-Ahnini","year":"2002","journal-title":"Tissue Antigens"},{"key":"10.1111\/bjd.16808-BIB0118|bjd16808-cit-0118","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1399-0039.2007.00992.x","article-title":"Genetic analysis of autoimmune regulator haplotypes in alopecia areata","volume":"71","author":"Wengraf","year":"2008","journal-title":"Tissue Antigens"},{"key":"10.1111\/bjd.16808-BIB0119|bjd16808-cit-0119","doi-asserted-by":"crossref","first-page":"e0127476","DOI":"10.1371\/journal.pone.0127476","article-title":"The AIRE-230Y polymorphism affects AIRE transcriptional activity: potential influence on AIRE function in the thymus","volume":"10","author":"Lovewell","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1111\/bjd.16808-BIB0120|bjd16808-cit-0120","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/jid.2012.17","article-title":"Increased expression of Cxcr3 and its ligands, Cxcl9, and Cxcl10, during the development of alopecia areata in the mouse","volume":"132","author":"McPhee","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16808-BIB0121|bjd16808-cit-0121","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.4049\/jimmunol.1501798","article-title":"CXCR3 blockade inhibits T cell migration into the skin and prevents development of alopecia areata","volume":"197","author":"Dai","year":"2016","journal-title":"J Immunol"},{"key":"10.1111\/bjd.16808-BIB0122|bjd16808-cit-0122","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/exd.12918","article-title":"Biomarkers of alopecia areata disease activity and response to corticosteroid treatment","volume":"25","author":"Fuentes-Duculan","year":"2016","journal-title":"Exp Dermatol"},{"key":"10.1111\/bjd.16808-BIB0123|bjd16808-cit-0123","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.cytogfr.2006.05.001","article-title":"IL-15\/IL-15 receptor biology: a guided tour through an expanding universe","volume":"17","author":"Budagian","year":"2006","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1111\/bjd.16808-BIB0124|bjd16808-cit-0124","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.4049\/jimmunol.1103609","article-title":"Cutting edge: the role of IFN-\u03b1 receptor and MyD88 signalling in induction of IL-15 expression in vivo","volume":"188","author":"Colpitts","year":"2012","journal-title":"J Immunol"},{"key":"10.1111\/bjd.16808-BIB0125|bjd16808-cit-0125","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nri3919","article-title":"IL-15 functions as a danger signal to regulate tissue-resident T cells and tissue destruction","volume":"15","author":"Jabri","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/bjd.16808-BIB0126|bjd16808-cit-0126","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/ni.2936","article-title":"The metabolic checkpoint kinase mTOR is essential for IL-15 signalling during the development and activation of NK cells","volume":"15","author":"Mar\u00e7ais","year":"2014","journal-title":"Nat Immunol"},{"key":"10.1111\/bjd.16808-BIB0127|bjd16808-cit-0127","doi-asserted-by":"crossref","first-page":"e76292","DOI":"10.1371\/journal.pone.0076292","article-title":"Interleukin 15 primes natural killer cells to kill via NKG2D and cPLA2 and this pathway is active in psoriatic arthritis","volume":"8","author":"Tang","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1111\/bjd.16808-BIB0128|bjd16808-cit-0128","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.4049\/jimmunol.167.10.5527","article-title":"Cutting edge: NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment","volume":"167","author":"Roberts","year":"2001","journal-title":"J Immunol"},{"key":"10.1111\/bjd.16808-BIB0129|bjd16808-cit-0129","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.immuni.2004.06.020","article-title":"Coordinated induction by IL15 of a TCR-independent NKG2D signalling pathway converts CTL into lymphokine-activated killer cells in celiac disease","volume":"21","author":"Meresse","year":"2004","journal-title":"Immunity"},{"key":"10.1111\/bjd.16808-BIB0130|bjd16808-cit-0130","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1084\/jem.20060028","article-title":"Reprogramming of CTLs into natural killer-like cells in celiac disease","volume":"203","author":"Meresse","year":"2006","journal-title":"J Exp Med"},{"key":"10.1111\/bjd.16808-BIB0131|bjd16808-cit-0131","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/ijd.12808","article-title":"T-helper 17 cytokines (interleukins 17, 21, 22, and 6, and tumour necrosis factor-\u03b1) in patients with alopecia areata: association with clinical type and severity","volume":"55","author":"Atwa","year":"2016","journal-title":"Int J Dermatol"},{"key":"10.1111\/bjd.16808-BIB0132|bjd16808-cit-0132","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/1346-8138.12978","article-title":"Imbalance of T-helper 17 and regulatory T cells in patients with alopecia areata","volume":"42","author":"Han","year":"2015","journal-title":"J Dermatol"},{"key":"10.1111\/bjd.16808-BIB0133|bjd16808-cit-0133","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/bjd.12396","article-title":"T-helper and regulatory T-cell cytokines in the peripheral blood of patients with active alopecia areata","volume":"169","author":"Tembhre","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.16808-BIB0134|bjd16808-cit-0134","doi-asserted-by":"crossref","first-page":"61","DOI":"10.5021\/ad.2012.24.1.61","article-title":"Association between IL17A\/IL17RA gene polymorphisms and susceptibility to alopecia areata in the Korean population","volume":"24","author":"Lew","year":"2012","journal-title":"Ann Dermatol"},{"key":"10.1111\/bjd.16808-BIB0135|bjd16808-cit-0135","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature09114","article-title":"Genome-wide association study in alopecia areata implicates both innate and adaptive immunity","volume":"466","author":"Petukhova","year":"2010","journal-title":"Nature"},{"key":"10.1111\/bjd.16808-BIB0136|bjd16808-cit-0136","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1001\/archdermatol.2010.42","article-title":"Renb\u00f6k phenomenon and contact sensitization in a patient with alopecia universalis","volume":"146","author":"Harris","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.16808-BIB0137|bjd16808-cit-0137","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1365-2230.2011.04097.x","article-title":"Renb\u00f6k phenomenon between psoriasis and alopecia areata","volume":"36","author":"Wylie","year":"2011","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/bjd.16808-BIB0138|bjd16808-cit-0138","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/1523-1747.ep12470601","article-title":"Immunohistological and ultrastructural comparison of the dermal papilla and hair follicle bulb from \u2018active\u2019 and \u2018normal\u2019 areas of alopecia areata","volume":"96","author":"Hull","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16808-BIB0139|bjd16808-cit-0139","doi-asserted-by":"crossref","first-page":"503587","DOI":"10.1155\/2010\/503587","article-title":"Serum interleukin-4 and total immunoglobulin E in nonatopic alopecia areata patients and HLA-DRB1 typing","volume":"2010","author":"Attia","year":"2010","journal-title":"Dermatol Res Pract"},{"key":"10.1111\/bjd.16808-BIB0140|bjd16808-cit-0140","first-page":"149","article-title":"Serum levels of total immunoglobulin E in patients with alopecia areata: relationship with clinical type of the disease","volume":"14","author":"Kasumagi\u0107-Halilovi\u0107","year":"2006","journal-title":"Acta Dermatovenerol Croat"},{"key":"10.1111\/bjd.16808-BIB0141|bjd16808-cit-0141","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/bjd.12980","article-title":"Vitamin D deficiency in alopecia areata","volume":"170","author":"Aksu Cerman","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.16808-BIB0142|bjd16808-cit-0142","doi-asserted-by":"crossref","first-page":"1000105","DOI":"10.4172\/2167-0390.1000105","article-title":"Vitamin D concentrations are decreased in patients with alopecia areata","volume":"1","author":"Yilmaz","year":"2012","journal-title":"Vitam Trace Elem"},{"key":"10.1111\/bjd.16808-BIB0143|bjd16808-cit-0143","doi-asserted-by":"crossref","first-page":"271","DOI":"10.4161\/derm.24411","article-title":"Reduced level of 25-hydroxyvitamin D in chronic\/relapsing alopecia areata","volume":"5","author":"d'Ovidio","year":"2013","journal-title":"Dermatoendocrinol"},{"key":"10.1111\/bjd.16808-BIB0144|bjd16808-cit-0144","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00403-016-1687-y","article-title":"Estimated serum vitamin D status, vitamin D intake, and risk of incident alopecia areata among US women","volume":"308","author":"Thompson","year":"2016","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/bjd.16808-BIB0145|bjd16808-cit-0145","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3109\/09546639109086760","article-title":"Alopecia totalis does not respond to the vitamin-D analogue calcipotriol","volume":"1","author":"Berth-Jones","year":"1991","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/bjd.16808-BIB0146|bjd16808-cit-0146","first-page":"616","article-title":"Topical calcipotriol therapy for mild-to-moderate alopecia areata: a retrospective study","volume":"14","author":"Cerman","year":"2015","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/bjd.16808-BIB0147|bjd16808-cit-0147","doi-asserted-by":"crossref","first-page":"341","DOI":"10.5021\/ad.2012.24.3.341","article-title":"Successful treatment of alopecia areata with topical calcipotriol","volume":"24","author":"Kim","year":"2012","journal-title":"Ann Dermatol"},{"key":"10.1111\/bjd.16808-BIB0148|bjd16808-cit-0148","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/09546639509080585","article-title":"Topical use of calcipotriol does not potentiate squaric acid dibutylester effectiveness in the treatment of alopecia areata","volume":"6","author":"Orecchia","year":"1995","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/bjd.16808-BIB0149|bjd16808-cit-0149","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/j.1365-4632.2007.03140.x","article-title":"Vitamin D receptor gene polymorphisms are not associated with alopecia areata","volume":"46","author":"Akar","year":"2007","journal-title":"Int J Dermatol"},{"key":"10.1111\/bjd.16808-BIB0150|bjd16808-cit-0150","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jtbi.2015.05.033","article-title":"Mathematical model for alopecia areata","volume":"380","author":"Dobreva","year":"2015","journal-title":"J Theor Biol"},{"key":"10.1111\/bjd.16808-BIB0151|bjd16808-cit-0151","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/sj.jidsp.5640237","article-title":"Peribulbar innervation and substance P expression following nonpermanent injury to the human scalp hair follicle","volume":"4","author":"Hordinsky","year":"1999","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1111\/bjd.16808-BIB0152|bjd16808-cit-0152","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1046\/j.1523-1747.1999.00791.x","article-title":"Hair cycle-dependent changes in adrenergic skin innervation, and hair growth modulation by adrenergic drugs","volume":"113","author":"Botchkarev","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16808-BIB0153|bjd16808-cit-0153","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1096\/fj.04-1968fje","article-title":"Human hair follicles display a functional equivalent of the hypothalamic-pituitary-adrenal axis and synthesize cortisol","volume":"19","author":"Ito","year":"2005","journal-title":"FASEB J"},{"key":"10.1111\/bjd.16808-BIB0154|bjd16808-cit-0154","doi-asserted-by":"crossref","first-page":"E701","DOI":"10.1152\/ajpendo.00519.2004","article-title":"CRH stimulation of corticosteroids production in melanocytes is mediated by ACTH","volume":"288","author":"Slominski","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1111\/bjd.16808-BIB0155|bjd16808-cit-0155","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1749-6632.1999.tb08690.x","article-title":"The skin POMC system (SPS): leads and lessons from the hair follicle","volume":"885","author":"Paus","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"10.1111\/bjd.16808-BIB0156|bjd16808-cit-0156","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.mce.2008.02.023","article-title":"(Neuro-)endocrinology of epithelial hair follicle stem cells","volume":"288","author":"Paus","year":"2008","journal-title":"Mol Cell Endocrinol"},{"key":"10.1111\/bjd.16808-BIB0157|bjd16808-cit-0157","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1365-4362.1996.tb05049.x","article-title":"Potential mechanism of skin response to stress","volume":"35","author":"Slominski","year":"1996","journal-title":"Int J Dermatol"},{"key":"10.1111\/bjd.16808-BIB0158|bjd16808-cit-0158","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1152\/physrev.2000.80.3.979","article-title":"Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress","volume":"80","author":"Slominski","year":"2000","journal-title":"Physiol Rev"},{"key":"10.1111\/bjd.16808-BIB0159|bjd16808-cit-0159","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1096\/fj.01-0254fje","article-title":"In situ expression of corticotropin-releasing hormone (CRH) and proopiomelanocortin (POMC) genes in human skin","volume":"15","author":"Kono","year":"2001","journal-title":"FASEB J"},{"key":"10.1111\/bjd.16808-BIB0160|bjd16808-cit-0160","first-page":"457","article-title":"Neuroendocrinology of the skin","volume":"21","author":"Slominski","year":"2000","journal-title":"Endocrine Rev"},{"key":"10.1111\/bjd.16808-BIB0161|bjd16808-cit-0161","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.it.2005.10.002","article-title":"Neuroimmunoendocrine circuitry of the \u2018brain-skin connection\u2019","volume":"27","author":"Paus","year":"2006","journal-title":"Trends Immunol"},{"key":"10.1111\/bjd.16808-BIB0162|bjd16808-cit-0162","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1210\/endo.139.1.5660","article-title":"Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects","volume":"139","author":"Theoharides","year":"1998","journal-title":"Endocrinology"},{"key":"10.1111\/bjd.16808-BIB0163|bjd16808-cit-0163","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1006\/brbi.1998.0541","article-title":"Acute immobilization stress triggers skin mast cell degranulation via corticotropin releasing hormone, neurotensin, and substance P: a link to neurogenic skin disorders","volume":"13","author":"Singh","year":"1999","journal-title":"Brain Behav Immun"},{"key":"10.1111\/bjd.16808-BIB0164|bjd16808-cit-0164","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.2353\/ajpath.2007.061206","article-title":"Probing the effects of stress mediators on the human hair follicle: substance P holds central position","volume":"171","author":"Peters","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1111\/bjd.16808-BIB0165|bjd16808-cit-0165","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0304-3940(96)13318-8","article-title":"Local injection of nerve growth factor (NGF) triggers degranulation of mast cells in rat paw","volume":"221","author":"Tal","year":"1997","journal-title":"Neurosci Lett"},{"key":"10.1111\/bjd.16808-BIB0166|bjd16808-cit-0166","doi-asserted-by":"crossref","first-page":"4478","DOI":"10.4049\/jimmunol.150.10.4478","article-title":"Substance P selectively activates TNF-\u03b1 gene expression in murine mast cells","volume":"150","author":"Ansel","year":"1993","journal-title":"J Immunol"},{"key":"10.1111\/bjd.16808-BIB0167|bjd16808-cit-0167","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0002-9440(10)63294-4","article-title":"Neurogenic inflammation in stress-induced termination of murine hair growth is promoted by nerve growth factor","volume":"165","author":"Peters","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1111\/bjd.16808-BIB0168|bjd16808-cit-0168","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2353\/ajpath.2006.050163","article-title":"p75 Neurotrophin receptor-mediated signalling promotes human hair follicle regression (catagen)","volume":"168","author":"Peters","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1111\/bjd.16808-BIB0169|bjd16808-cit-0169","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.molmed.2014.06.002","article-title":"Neuroendocrinology of the hair follicle: principles and clinical perspectives","volume":"20","author":"Paus","year":"2014","journal-title":"Trends Mol Med"},{"key":"10.1111\/bjd.16808-BIB0170|bjd16808-cit-0170","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0002-9440(10)63877-1","article-title":"Stress inhibits hair growth in mice by induction of premature catagen development and deleterious perifollicular inflammatory events via neuropeptide substance P-dependent pathways","volume":"162","author":"Arck","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1111\/bjd.16808-BIB0171|bjd16808-cit-0171","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1096\/fj.00-0699fje","article-title":"Indications for a \u2018brain-hair follicle axis (BHA)\u2019: inhibition of keratinocyte proliferation and up-regulation of keratinocyte apoptosis in telogen hair follicles by stress and substance P","volume":"15","author":"Arck","year":"2001","journal-title":"FASEB J"},{"key":"10.1111\/bjd.16808-BIB0172|bjd16808-cit-0172","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0002-9440(10)63866-7","article-title":"Stress and the hair follicle: exploring the connections","volume":"162","author":"Botchkarev","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1111\/bjd.16808-BIB0173|bjd16808-cit-0173","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1600-0625.2007.00558.x","article-title":"Foot shock stress prolongs the telogen stage of the spontaneous hair cycle in a non-depilated mouse model","volume":"16","author":"Katayama","year":"2007","journal-title":"Exp Dermatol"},{"key":"10.1111\/bjd.16808-BIB0174|bjd16808-cit-0174","doi-asserted-by":"crossref","first-page":"e94260","DOI":"10.1371\/journal.pone.0094260","article-title":"Abnormal interactions between perifollicular mast cells and CD8+ T-cells may contribute to the pathogenesis of alopecia areata","volume":"9","author":"Bertolini","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1111\/bjd.16808-BIB0175|bjd16808-cit-0175","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1046\/j.1365-2133.2001.03951.x","article-title":"Expression of neuropeptide-degrading enzymes in alopecia areata: an immunohistochemical study","volume":"144","author":"Toyoda","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.16808-BIB0176|bjd16808-cit-0176","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1600-0625.2006.00003.x","article-title":"Immunoreactivity of corticotropin-releasing hormone, adrenocorticotropic hormone and \u03b1-melanocyte-stimulating hormone in alopecia areata","volume":"15","author":"Kim","year":"2006","journal-title":"Exp Dermatol"},{"key":"10.1111\/bjd.16808-BIB0177|bjd16808-cit-0177","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1038\/jid.2008.371","article-title":"Development of alopecia areata is associated with higher central and peripheral hypothalamic-pituitary-adrenal tone in the skin graft induced C3H\/HeJ mouse model","volume":"129","author":"Zhang","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16808-BIB0178|bjd16808-cit-0178","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1084\/jem.194.6.863","article-title":"Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens","volume":"194","author":"Kadowaki","year":"2001","journal-title":"J Exp Med"},{"key":"10.1111\/bjd.16808-BIB0179|bjd16808-cit-0179","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1182\/blood-2010-02-258558","article-title":"Nomenclature of monocytes and dendritic cells in blood","volume":"116","author":"Ziegler-Heitbrock","year":"2010","journal-title":"Blood"},{"key":"10.1111\/bjd.16808-BIB0180|bjd16808-cit-0180","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/ni1141","article-title":"Plasmacytoid dendritic cells in immunity","volume":"5","author":"Colonna","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1111\/bjd.16808-BIB0181|bjd16808-cit-0181","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1684\/ejd.2010.0816","article-title":"Plasmacytoid dendritic cells and dermatological disorders: focus on their role in autoimmunity and cancer","volume":"20","author":"Charles","year":"2010","journal-title":"Eur J Dermatol"},{"key":"10.1111\/bjd.16808-BIB0182|bjd16808-cit-0182","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.smim.2011.01.006","article-title":"Harnessing dendritic cells in inflammatory skin diseases","volume":"23","author":"Chu","year":"2011","journal-title":"Semin Immunol"},{"key":"10.1111\/bjd.16808-BIB0183|bjd16808-cit-0183","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1084\/jem.20090480","article-title":"Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8","volume":"206","author":"Ganguly","year":"2009","journal-title":"J Exp Med"},{"key":"10.1111\/bjd.16808-BIB0184|bjd16808-cit-0184","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1084\/jem.20050500","article-title":"Plasmacytoid predendritic cells initiate psoriasis through interferon-\u03b1 production","volume":"202","author":"Nestle","year":"2005","journal-title":"J Exp Med"},{"key":"10.1111\/bjd.16808-BIB0185|bjd16808-cit-0185","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1001\/archderm.1992.01680130082010","article-title":"Incidence of alopecia areata in lupus erythematosus","volume":"128","author":"Werth","year":"1992","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.16808-BIB0186|bjd16808-cit-0186","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jaad.2010.08.032","article-title":"Comorbidity profiles among patients with alopecia areata: the importance of onset age, a nationwide population-based study","volume":"65","author":"Chu","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.16808-BIB0187|bjd16808-cit-0187","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jaad.2012.04.039","article-title":"The association of psoriasis with autoimmune diseases","volume":"67","author":"Wu","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.16808-BIB0188|bjd16808-cit-0188","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/jdv.12932","article-title":"Plasmacytoid dendritic cells in alopecia areata: missing link?","volume":"30","author":"Abou Rahal","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.16808-BIB0189|bjd16808-cit-0189","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2133.2010.09775.x","article-title":"Type 1 interferon signature in the scalp lesions of alopecia areata","volume":"163","author":"Ghoreishi","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.16808-BIB0190|bjd16808-cit-0190","doi-asserted-by":"crossref","first-page":"39765","DOI":"10.1074\/jbc.M102502200","article-title":"Interferon-\u03ba, a novel type I interferon expressed in human keratinocytes","volume":"276","author":"LaFleur","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1111\/bjd.16808-BIB0191|bjd16808-cit-0191","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000065841","article-title":"Alopecia areata during interferon \u03b1-2b\/ribavirin therapy","volume":"205","author":"Agesta","year":"2002","journal-title":"Dermatology"},{"key":"10.1111\/bjd.16808-BIB0192|bjd16808-cit-0192","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000079904","article-title":"Alopecia areata induced by adjuvant treatment with \u03b1-interferon in malignant melanoma?","volume":"209","author":"Radny","year":"2004","journal-title":"Dermatology"},{"key":"10.1111\/bjd.16808-BIB0193|bjd16808-cit-0193","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1007\/s12325-017-0540-9","article-title":"The changing landscape of alopecia areata: the translational landscape","volume":"34","author":"Wang","year":"2017","journal-title":"Adv Ther"},{"key":"10.1111\/bjd.16808-BIB0194|bjd16808-cit-0194","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.pharmthera.2017.05.008","article-title":"Mechanisms of tolerance and potential therapeutic interventions in alopecia areata","volume":"179","author":"Skogberg","year":"2017","journal-title":"Pharmacol Ther"},{"key":"10.1111\/bjd.16808-BIB0195|bjd16808-cit-0195","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/sj.jidsp.5640215","article-title":"Alopecia areata in families: association with the HLA locus","volume":"4","author":"De Andrade","year":"1999","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1111\/bjd.16808-BIB0196|bjd16808-cit-0196","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/sj.jid.5700009","article-title":"Major histocompatibility complex class I chain-related gene A polymorphisms and extended haplotypes are associated with familial alopecia areata","volume":"126","author":"Barahmani","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16808-BIB0197|bjd16808-cit-0197","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s00439-002-0898-9","article-title":"Notch4, a non-HLA gene in the MHC is strongly associated with the most severe form of alopecia areata","volume":"112","author":"Tazi-Ahnini","year":"2003","journal-title":"Hum Genet"},{"key":"10.1111\/bjd.16808-BIB0198|bjd16808-cit-0198","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1399-0039.2006.00598.x","article-title":"Investigation of the p.Ser278Arg polymorphism of the autoimmune regulator (AIRE) gene in alopecia areata","volume":"68","author":"Pforr","year":"2006","journal-title":"Tissue Antigens"},{"key":"10.1111\/bjd.16808-BIB0199|bjd16808-cit-0199","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1126\/science.1160062","article-title":"CTLA-4 control over Foxp3+ regulatory T cell function","volume":"322","author":"Wing","year":"2008","journal-title":"Science"},{"key":"10.1111\/bjd.16808-BIB0200|bjd16808-cit-0200","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1126\/science.1176077","article-title":"Eos mediates Foxp3-dependent gene silencing in CD4+ regulatory T cells","volume":"325","author":"Pan","year":"2009","journal-title":"Science"},{"key":"10.1111\/bjd.16808-BIB0201|bjd16808-cit-0201","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.humimm.2006.04.006","article-title":"The non-synonymous C1858T substitution in the PTPN22 gene is associated with susceptibility to the severe forms of alopecia areata","volume":"67","author":"Kemp","year":"2006","journal-title":"Hum Immunol"},{"key":"10.1111\/bjd.16808-BIB0202|bjd16808-cit-0202","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.3892\/etm.2015.2728","article-title":"Association between PTPN22 C1858T polymorphism and alopecia areata risk","volume":"10","author":"Salinas-Santander","year":"2015","journal-title":"Exp Ther Med"},{"key":"10.1111\/bjd.16808-BIB0203|bjd16808-cit-0203","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.humimm.2013.09.003","article-title":"PTPN22 profile indicates a novel risk group in alopecia areata","volume":"75","author":"Bhanusali","year":"2014","journal-title":"Hum Immunol"},{"key":"10.1111\/bjd.16808-BIB0204|bjd16808-cit-0204","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.gene.2013.03.070","article-title":"PTPN22 gene polymorphism in Egyptian alopecia areata patients and its impact on response to diphencyprone immunotherapy","volume":"523","author":"El-Zawahry","year":"2013","journal-title":"Gene"},{"key":"10.1111\/bjd.16808-BIB0205|bjd16808-cit-0205","first-page":"389","article-title":"The R620W polymorphism in PTPN22 confers general susceptibility for the development of alopecia areata","volume":"158","author":"Betz","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.16808-BIB0206|bjd16808-cit-0206","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1365-2370.2002.00271.x","article-title":"Genetic analysis of the interleukin-1 receptor antagonist and its homologue IL-1L1 in alopecia areata: strong severity association and possible gene interaction","volume":"29","author":"Tazi-Ahnini","year":"2002","journal-title":"Eur J Immunogenet"},{"key":"10.1111\/bjd.16808-BIB0207|bjd16808-cit-0207","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1046\/j.0022-202x.2001.01676.x","article-title":"Interleukin-1 receptor antagonist allele 2 and familial alopecia areata","volume":"118","author":"Barahamani","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16808-BIB0208|bjd16808-cit-0208","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/1523-1747.ep12395398","article-title":"Severity of alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene","volume":"103","author":"Tarlow","year":"1994","journal-title":"J Invest Dermatol"},{"issue":"5 Suppl.","key":"10.1111\/bjd.16808-BIB0209|bjd16808-cit-0209","doi-asserted-by":"crossref","first-page":"15S","DOI":"10.1038\/jid.1995.37","article-title":"An allele of the interleukin-1 receptor antagonist as a genetic severity factor in alopecia areata","volume":"104","author":"Cork","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16808-BIB0210|bjd16808-cit-0210","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.tips.2009.05.006","article-title":"Interleukin-21 as a new therapeutic target for immune-mediated diseases","volume":"30","author":"Monteleone","year":"2009","journal-title":"Trends Pharmacol Sci"},{"key":"10.1111\/bjd.16808-BIB0211|bjd16808-cit-0211","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.gene.2013.05.086","article-title":"The association between interleukin (IL)-4 gene intron 3 VNTR polymorphism and alopecia areata (AA) in Turkish population","volume":"527","author":"Kalkan","year":"2013","journal-title":"Gene"},{"key":"10.1111\/bjd.16808-BIB0212|bjd16808-cit-0212","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/nri2870","article-title":"Functions of T cells in asthma: more than just TH2 cells","volume":"10","author":"Lloyd","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/bjd.16808-BIB0213|bjd16808-cit-0213","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1038\/jid.2012.129","article-title":"Follow-up study of the first genome-wide association scan in alopecia areata: IL13 and KIAA0350 as susceptibility loci supported with genome-wide significance","volume":"132","author":"Jagielska","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16808-BIB0214|bjd16808-cit-0214","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/ijd.12251","article-title":"Association between IL16 gene polymorphisms and susceptibility to alopecia areata in the Korean population","volume":"53","author":"Lew","year":"2014","journal-title":"Int J Dermatol"},{"key":"10.1111\/bjd.16808-BIB0215|bjd16808-cit-0215","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1089\/jir.2013.0055","article-title":"Association between interleukin 18 polymorphisms and alopecia areata in Koreans","volume":"34","author":"Kim","year":"2014","journal-title":"J Interferon Cytokine Res"},{"key":"10.1111\/bjd.16808-BIB0216|bjd16808-cit-0216","first-page":"639","article-title":"Structure and polymorphism of the human gene for the interferon-induced p78 protein (MX1): evidence of association with alopecia areata in the Down syndrome region","volume":"106","author":"Tazi-Ahnini","year":"2000","journal-title":"Hum Genet"},{"key":"10.1111\/bjd.16808-BIB0217|bjd16808-cit-0217","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0923-1811(02)00015-4","article-title":"Antioxidant enzymes and lipid peroxidation in the scalp of patients with alopecia areata","volume":"29","author":"Akar","year":"2002","journal-title":"J Dermatol Sci"},{"key":"10.1111\/bjd.16808-BIB0218|bjd16808-cit-0218","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1348-0421.2005.tb03640.x","article-title":"Autoantibodies to peroxiredoxin I and IV in patients with systemic autoimmune diseases","volume":"49","author":"Karasawa","year":"2005","journal-title":"Microbiol Immunol"},{"key":"10.1111\/bjd.16808-BIB0219|bjd16808-cit-0219","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/ng.185","article-title":"A cis-acting regulatory mutation causes premature hair graying and susceptibility to melanoma in the horse","volume":"40","author":"Pielberg","year":"2008","journal-title":"Nat Genet"},{"key":"10.1111\/bjd.16808-BIB0220|bjd16808-cit-0220","doi-asserted-by":"crossref","first-page":"13439","DOI":"10.1073\/pnas.0901965106","article-title":"Expression of GARP selectively identifies activated human FOXP3+ regulatory T cells","volume":"106","author":"Wang","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/bjd.16808-BIB0221|bjd16808-cit-0221","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/ard.2008.098376","article-title":"Chromosomal region 16p13: further evidence of increased predisposition to immune diseases","volume":"69","author":"Martinez","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/bjd.16808-BIB0222|bjd16808-cit-0222","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0300-483X(02)00552-8","article-title":"Species variations in cutaneous alcohol dehydrogenases and aldehyde dehydrogenases may impact on toxicological assessments of alcohols and aldehydes","volume":"184","author":"Cheung","year":"2003","journal-title":"Toxicology"},{"key":"10.1111\/bjd.16808-BIB0223|bjd16808-cit-0223","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1365-4632.2004.02028.x","article-title":"The role of psychological factors in alopecia areata and the impact of the disease on the quality of life","volume":"43","author":"G\u00fcle\u00e7","year":"2004","journal-title":"Int J Dermatol"},{"key":"10.1111\/bjd.16808-BIB0224|bjd16808-cit-0224","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/j.1346-8138.2003.tb00341.x","article-title":"Roles of stress, stress perception and trait-anxiety in the onset and course of alopecia areata","volume":"30","author":"Brajac","year":"2003","journal-title":"J Dermatol"},{"key":"10.1111\/bjd.16808-BIB0225|bjd16808-cit-0225","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1176\/appi.psy.44.5.374","article-title":"Psychosomatic factors in first-onset alopecia areata","volume":"44","author":"Picardi","year":"2003","journal-title":"Psychosomatics"},{"key":"10.1111\/bjd.16808-BIB0226|bjd16808-cit-0226","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1001\/jama.1995.03520420031025","article-title":"Alopecia areata and presence of cytomegalovirus DNA","volume":"273","author":"Skinner","year":"1995","journal-title":"JAMA"},{"key":"10.1111\/bjd.16808-BIB0227|bjd16808-cit-0227","first-page":"169","article-title":"No correlation between cytomegalovirus and alopecia areata","volume":"14","author":"Tosti","year":"1997","journal-title":"Pediatr Dermatol"},{"key":"10.1111\/bjd.16808-BIB0228|bjd16808-cit-0228","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jaad.2008.02.005","article-title":"Onset of alopecia areata after Epstein-Barr virus infectious mononucleosis","volume":"59","author":"Rodriguez","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.16808-BIB0229|bjd16808-cit-0229","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1346-8138.2011.01437.x","article-title":"Alopecia areata triggered or exacerbated by swine flu virus infection","volume":"39","author":"Ito","year":"2012","journal-title":"J Dermatol"},{"key":"10.1111\/bjd.16808-BIB0230|bjd16808-cit-0230","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/ijd.12769","article-title":"Evaluation of serum zinc level in patients with newly diagnosed and resistant alopecia areata","volume":"55","author":"Fattah","year":"2016","journal-title":"Int J Dermatol"},{"key":"10.1111\/bjd.16808-BIB0231|bjd16808-cit-0231","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/1346-8138.13705","article-title":"Changes of serum trace elements level in patients with alopecia areata: a meta-analysis","volume":"44","author":"Jin","year":"2017","journal-title":"J Dermatol"},{"key":"10.1111\/bjd.16808-BIB0232|bjd16808-cit-0232","doi-asserted-by":"crossref","first-page":"784863","DOI":"10.1155\/2014\/784863","article-title":"Comparison of Zn, Cu, and Fe content in hair and serum in alopecia areata patients with normal group","volume":"2014","author":"Dastgheib","year":"2014","journal-title":"Dermatol Res Pract"},{"key":"10.1111\/bjd.16808-BIB0233|bjd16808-cit-0233","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s40257-017-0285-x","article-title":"The role of micronutrients in alopecia areata: a review","volume":"18","author":"Thompson","year":"2017","journal-title":"Am J Clin Dermatol"},{"key":"10.1111\/bjd.16808-BIB0234|bjd16808-cit-0234","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1001\/jama.1997.03550140068042","article-title":"Hair loss after routine immunizations","volume":"278","author":"Wise","year":"1997","journal-title":"JAMA"},{"key":"10.1111\/bjd.16808-BIB0235|bjd16808-cit-0235","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-3164.2008.00692.x","article-title":"Recombinant human hepatitis B vaccine initiating alopecia areata: testing the hypothesis using the C3H\/HeJ mouse model","volume":"20","author":"Sundberg","year":"2009","journal-title":"Vet Dermatol"},{"key":"10.1111\/bjd.16808-BIB0236|bjd16808-cit-0236","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/ced.12471","article-title":"Allergy to dust mites may contribute to early onset and severity of alopecia areata","volume":"40","author":"Li","year":"2015","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/bjd.16808-BIB0237|bjd16808-cit-0237","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/sj.jid.5700328","article-title":"A chronic contact eczema impedes migration of antigen-presenting cells in alopecia areata","volume":"126","author":"Gupta","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16808-BIB0238|bjd16808-cit-0238","first-page":"537","article-title":"Diphenylcyclopropenone treatment of alopecia areata induces apoptosis of perifollicular lymphocytes","volume":"16","author":"Herbst","year":"2006","journal-title":"Eur J Dermatol"},{"key":"10.1111\/bjd.16808-BIB0239|bjd16808-cit-0239","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00403-007-0759-4","article-title":"Changes in distribution pattern of CD8 lymphocytes in the scalp in alopecia areata during treatment with diphencyprone","volume":"299","author":"Wasy\u0142yszyn","year":"2007","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/bjd.16808-BIB0240|bjd16808-cit-0240","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/1346-8138.12740","article-title":"Effective squaric acid dibutylester immunotherapy is associated with a reduction of skin infiltrating T-helper (Th) 1 and Th17 cells in alopecia areata patients","volume":"42","author":"Avitabile","year":"2015","journal-title":"J Dermatol"},{"key":"10.1111\/bjd.16808-BIB0241|bjd16808-cit-0241","first-page":"1063","article-title":"Predictive model for immunotherapy of alopecia areata with diphencyprone","volume":"137","author":"Wiseman","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.16808-BIB0242|bjd16808-cit-0242","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0190-9622(98)70048-9","article-title":"Efficacy of topical sensitizers in the treatment of alopecia areata","volume":"39","author":"Rokhsar","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.16808-BIB0243|bjd16808-cit-0243","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.clindermatol.2014.12.001","article-title":"Treatment of alopecia areata with squaric acid dibutylester","volume":"33","author":"Hill","year":"2015","journal-title":"Clin Dermatol"},{"key":"10.1111\/bjd.16808-BIB0244|bjd16808-cit-0244","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s13555-018-0226-5","article-title":"Topical immunotherapy of alopecia areata: a large retrospective study","volume":"8","author":"Zerbinati","year":"2018","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1111\/bjd.16808-BIB0245|bjd16808-cit-0245","first-page":"256","article-title":"Discussion (society transactions)","volume":"112","author":"Rosenberg","year":"1976","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.16808-BIB0246|bjd16808-cit-0246","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1001\/archderm.1978.01640190024007","article-title":"Treatment of alopecia areata with dinitrochlorobenzene","volume":"114","author":"Daman","year":"1978","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.16808-BIB0247|bjd16808-cit-0247","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ebiom.2015.02.015","article-title":"Reversal of alopecia areata following treatment with the JAK1\/2 inhibitor baricitinib","volume":"2","author":"Jabbari","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1111\/bjd.16808-BIB0248|bjd16808-cit-0248","doi-asserted-by":"crossref","first-page":"650","DOI":"10.2353\/ajpath.2008.061249","article-title":"Controlled delivery of T-box21 small interfering RNA ameliorates autoimmune alopecia (alopecia areata) in a C3H\/HeJ mouse model","volume":"172","author":"Nakamura","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1111\/bjd.16808-BIB0249|bjd16808-cit-0249","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1080\/09546634.2016.1277179","article-title":"Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature","volume":"28","author":"Samadi","year":"2017","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/bjd.16808-BIB0250|bjd16808-cit-0250","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jaad.2014.11.006","article-title":"Treatment of alopecia areata with simvastatin\/ezetimibe","volume":"72","author":"Lattouf","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.16808-BIB0251|bjd16808-cit-0251","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/jid.2014.529","article-title":"Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo","volume":"135","author":"Agarwal","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16808-BIB0252|bjd16808-cit-0252","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.jisp.2017.10.013","article-title":"Treatment of alopecia areata with simvastatin\/ezetimibe","volume":"19","author":"Cervantes","year":"2018","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1111\/bjd.16808-BIB0253|bjd16808-cit-0253","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1016\/j.jaad.2015.09.071","article-title":"Alopecia areata (AA) and treatment with simvastatin\/ezetimibe: experience of 20 patients","volume":"74","author":"Loi","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.16808-BIB0254|bjd16808-cit-0254","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000468991","article-title":"Unsuccessful treatment of alopecia areata with simvastatin\/ezetimibe: experience in 12 patients","volume":"3","author":"Gouveia","year":"2017","journal-title":"Skin Append Disord"},{"key":"10.1111\/bjd.16808-BIB0255|bjd16808-cit-0255","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jdermsci.2014.11.009","article-title":"The PDE4 inhibitor, apremilast, suppresses experimentally induced alopecia areata in human skin in vivo","volume":"77","author":"Keren","year":"2015","journal-title":"J Dermatol Sci"},{"key":"10.1111\/bjd.16808-BIB0256|bjd16808-cit-0256","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jaad.2017.05.034","article-title":"Lack of efficacy of apremilast in 9 patients with severe alopecia areata","volume":"77","author":"Liu","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.16808-BIB0257|bjd16808-cit-0257","first-page":"2","article-title":"Alopecia areata and severe psoriasis successfully treated with apremilast","volume":"1","author":"L\u00f3pez","year":"2017","journal-title":"Arch Clin Dermatol"},{"key":"10.1111\/bjd.16808-BIB0258|bjd16808-cit-0258","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1001\/jamadermatol.2014.504","article-title":"Effects of low-dose recombinant interleukin 2 to promote T-regulatory cells in alopecia areata","volume":"150","author":"Castela","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1111\/bjd.16808-BIB0259|bjd16808-cit-0259","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.0022-202X.2005.10130_6.x","article-title":"Treatment of alopecia areata with anti-interferon-\u03b3 antibodies","volume":"10","author":"Skurkovich","year":"2005","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1111\/bjd.16808-BIB0260|bjd16808-cit-0260","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1468-3083.2010.03770.x","article-title":"Alopecia areata as another immune-mediated disease developed in patients treated with tumour necrosis factor-\u03b1 blocker agents","volume":"25","author":"Ferran","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.16808-BIB0261|bjd16808-cit-0261","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1177\/120347541201600407","article-title":"Safety and efficacy of adalimumab for the treatment of severe alopecia areata: case series of three patients","volume":"16","author":"Bolduc","year":"2012","journal-title":"J Cutan Med Surg"},{"key":"10.1111\/bjd.16808-BIB0262|bjd16808-cit-0262","first-page":"892","article-title":"Development of alopecia areata after biological therapy with TNF-\u03b1 blockers: description of a case and review of the literature","volume":"27","author":"Hernandez","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1111\/bjd.16808-BIB0263|bjd16808-cit-0263","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1540-9740.2006.05443.x","article-title":"Failure of two TNF-\u03b1 blockers to influence the course of alopecia areata","volume":"5","author":"Abramovits","year":"2006","journal-title":"Skinmed"},{"key":"10.1111\/bjd.16808-BIB0264|bjd16808-cit-0264","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1001\/jamadermatol.2014.1544","article-title":"Alopecia universalis successfully treated with adalimumab","volume":"150","author":"Gorcey","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1111\/bjd.16808-BIB0265|bjd16808-cit-0265","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jaad.2005.03.039","article-title":"Etanercept does not effectively treat moderate to severe alopecia areata: an open-label study","volume":"52","author":"Strober","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.16808-BIB0266|bjd16808-cit-0266","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1365-2133.2012.10955.x","article-title":"British Association of Dermatologists\u2019 guidelines for the management of alopecia areata 2012","volume":"166","author":"Messenger","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.16808-BIB0267|bjd16808-cit-0267","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jaci.2015.11.001","article-title":"Extensive alopecia areata is reversed by IL-12\/IL-23p40 cytokine antagonism","volume":"137","author":"Guttman-Yassky","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/bjd.16808-BIB0268|bjd16808-cit-0268","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/MOP.0000000000000375","article-title":"Understanding autoimmunity of vitiligo and alopecia areata","volume":"28","author":"Rork","year":"2016","journal-title":"Curr Opin Pediatr"},{"key":"10.1111\/bjd.16808-BIB0269|bjd16808-cit-0269","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3315\/jdcr.2010.1041","article-title":"Alopecia areata developing paralell to improvement of psoriasis during ustekinumab therapy","volume":"4","author":"S\u0142owi\u0144ska","year":"2010","journal-title":"J Dermatol Case Rep"},{"key":"10.1111\/bjd.16808-BIB0270|bjd16808-cit-0270","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1001\/archdermatol.2009.264","article-title":"Alefacept for severe alopecia areata: a randomized, double-blind, placebo-controlled study","volume":"145","author":"Strober","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.16808-BIB0271|bjd16808-cit-0271","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1001\/archderm.141.12.1513","article-title":"Alefacept for alopecia areata","volume":"141","author":"Heffernan","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.16808-BIB0272|bjd16808-cit-0272","first-page":"431","article-title":"Successful treatment of alopecia universalis with alefacept: a case report and review of the literature","volume":"81","author":"Bui","year":"2008","journal-title":"Cutis"},{"key":"10.1111\/bjd.16808-BIB0273|bjd16808-cit-0273","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaad.2007.10.645","article-title":"Subcutaneous efalizumab is not effective in the treatment of alopecia areata","volume":"58","author":"Price","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.16808-BIB0274|bjd16808-cit-0274","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jaad.2006.05.062","article-title":"Treatment of alopecia areata partim universalis with efalizumab","volume":"55","author":"Kaelin","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.16808-BIB0275|bjd16808-cit-0275","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1111\/j.1468-3083.2008.02665.x","article-title":"Successful treatment of alopecia areata with efalizumab","volume":"22","author":"Kolde","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.16808-BIB0276|bjd16808-cit-0276","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1038\/jid.2013.141","article-title":"Blocking potassium channels (Kv1.3): a new treatment option for alopecia areata?","volume":"133","author":"Gilhar","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16808-BIB0277|bjd16808-cit-0277","doi-asserted-by":"crossref","first-page":"33432","DOI":"10.18632\/oncotarget.16504","article-title":"SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction","volume":"8","author":"Gao","year":"2017","journal-title":"Oncotarget"},{"key":"10.1111\/bjd.16808-BIB0278|bjd16808-cit-0278","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1046\/j.1523-1747.2002.01811.x","article-title":"Gene array profiling and immunomodulation studies define a cell-mediated immune response underlying the pathogenesis of alopecia areata in a mouse model and humans","volume":"119","author":"Carroll","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16808-BIB0279|bjd16808-cit-0279","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1038\/jid.2011.203","article-title":"Hypothesis testing: CTLA4 co-stimulatory pathways critical in the pathogenesis of human and mouse alopecia areata","volume":"131","author":"Sundberg","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16808-BIB0280|bjd16808-cit-0280","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1189\/jlb.0413196","article-title":"Tolerance induction by hair-specific keratins in murine alopecia areata","volume":"94","author":"Erb","year":"2013","journal-title":"J Leucoc Biol"},{"key":"10.1111\/bjd.16808-BIB0281|bjd16808-cit-0281","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1046\/j.1523-1747.2000.00113.x","article-title":"Treatment with an anti-CD44v10-specific antibody inhibits the onset of alopecia areata in C3H\/HeJ mice","volume":"115","author":"Freyschmidt-Paul","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16808-BIB0282|bjd16808-cit-0282","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.jisp.2017.10.014","article-title":"Hair follicle immune privilege revisited: the key to alopecia areata management","volume":"19","author":"Paus","year":"2018","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1111\/bjd.16808-BIB0283|bjd16808-cit-0283","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.tips.2004.09.007","article-title":"Mast cells as targets of corticotropin-releasing factor and related peptides","volume":"25","author":"Theoharides","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"10.1111\/bjd.16808-BIB0284|bjd16808-cit-0284","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1517\/14728220903551304","article-title":"Autoimmune diseases: MIF as a therapeutic target","volume":"14","author":"Greven","year":"2010","journal-title":"Expert Opin Ther Targets"},{"key":"10.1111\/bjd.16808-BIB0285|bjd16808-cit-0285","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/exd.12335","article-title":"Leptin controls hair follicle cycling","volume":"23","author":"Watabe","year":"2014","journal-title":"Exp Dermatol"},{"key":"10.1111\/bjd.16808-BIB0286|bjd16808-cit-0286","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/j.0022-202X.2005.23693.x","article-title":"Comprehensive analysis of FGF and FGFR expression in skin: FGF18 is highly expressed in hair follicles and capable of inducing anagen from telogen stage hair follicles","volume":"124","author":"Kawano","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16808-BIB0287|bjd16808-cit-0287","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1016\/j.ymthe.2017.07.010","article-title":"Epidermal E-cadherin dependent \u03b2-catenin pathway is phytochemical inducible and accelerates anagen hair cycling","volume":"25","author":"Ahmed","year":"2017","journal-title":"Mol Ther"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.16808","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.16808\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T23:17:21Z","timestamp":1720307841000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/179\/5\/1033\/6732534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,9]]},"references-count":287,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,11]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.16808","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9,9]]}}}